Metsmall GV 2 Tablet SR
Metsmall GV 2 Tablet SR
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Metsmall GV 2 Tablet SR is a sustained-release oral medication indicated for the management of type 2 diabetes mellitus. This combination tablet contains three active ingredients: glimepiride, a sulfonylurea anti-diabetic agent, metformin, a biguanide anti-diabetic agent, and voglibose, an alpha-glucosidase inhibitor. The tablet is designed to provide a controlled release of these ingredients over an extended period, thereby maintaining therapeutic efficacy while minimizing peak concentrations and associated side effects. The recommended dose is one tablet once daily, taken with breakfast or the first main meal of the day. The patient should be counseled on the importance of regular monitoring of blood glucose levels and the need to adjust diet and exercise regimens as necessary. Additionally, patients should be informed of the potential risks of hypoglycemia and the need to take the tablet with caution, particularly in patients with impaired renal function, liver disease, or those taking other medications that may increase the risk of hypoglycemia.
Active composition
Metformin 500 mg
+2 more active ingredients
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Glimepiride
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Metsmall GV 2 Tablet SR.
High Risk
Pregnancy
Metsmall GV 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Metsmall GV 2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Metsmall GV 2 Tablet SR may be needed. Please consult your doctor. Metsmall GV 2 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Metsmall GV 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Metsmall GV 2 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Metsmall GV 2 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Metsmall GV 2 Tablet SR
